These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 24124567

  • 21. Ac-SDKP ameliorates the progression of experimental autoimmune encephalomyelitis via inhibition of ER stress and oxidative stress in the hippocampus of C57BL/6 mice.
    Pejman S, Kamarehei M, Riazi G, Pooyan S, Balalaie S.
    Brain Res Bull; 2020 Jan; 154():21-31. PubMed ID: 31589901
    [Abstract] [Full Text] [Related]

  • 22. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells.
    Lee MJ, Jang M, Choi J, Chang BS, Kim DY, Kim SH, Kwak YS, Oh S, Lee JH, Chang BJ, Nah SY, Cho IH.
    Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819
    [Abstract] [Full Text] [Related]

  • 23. Oxidative stress modulates the cytokine response of differentiated Th17 and Th1 cells.
    Abimannan T, Peroumal D, Parida JR, Barik PK, Padhan P, Devadas S.
    Free Radic Biol Med; 2016 Oct; 99():352-363. PubMed ID: 27567538
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells.
    Alabanza LM, Esmon NL, Esmon CT, Bynoe MS.
    J Immunol; 2013 Oct 01; 191(7):3764-77. PubMed ID: 23997223
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
    Souza-Moreira L, Delgado-Maroto V, Morell M, O'Valle F, Del Moral RG, Gonzalez-Rey E.
    Brain Behav Immun; 2013 May 01; 30():54-60. PubMed ID: 23376169
    [Abstract] [Full Text] [Related]

  • 26. Bacoside-A inhibits inflammatory cytokines and chemokine in experimental autoimmune encephalomyelitis.
    Madhu K, T P, S M.
    Biomed Pharmacother; 2019 Jan 01; 109():1339-1345. PubMed ID: 30551384
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
    Gao Q, Zhang Y, Han C, Hu X, Zhang H, Xu X, Tian J, Liu Y, Ding Y, Liu J, Wang C, Guo Z, Yang Y, Cao X.
    J Autoimmun; 2016 May 01; 69():74-85. PubMed ID: 26994903
    [Abstract] [Full Text] [Related]

  • 35. Surfactant protein A is expressed in the central nervous system of rats with experimental autoimmune encephalomyelitis, and suppresses inflammation in human astrocytes and microglia.
    Yang X, Yan J, Feng J.
    Mol Med Rep; 2017 Jun 01; 15(6):3555-3565. PubMed ID: 28393255
    [Abstract] [Full Text] [Related]

  • 36. Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
    Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M.
    Immunol Invest; 2015 Jun 01; 44(7):694-712. PubMed ID: 26436854
    [Abstract] [Full Text] [Related]

  • 37. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
    Feng M, Shu Y, Yang Y, Zheng X, Li R, Wang Y, Dai Y, Qiu W, Lu Z, Hu X.
    Neurochem Int; 2014 Jan 01; 64():64-72. PubMed ID: 24274996
    [Abstract] [Full Text] [Related]

  • 38. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
    Dusi S, Angiari S, Pietronigro EC, Lopez N, Angelini G, Zenaro E, Della Bianca V, Tosadori G, Paris F, Amoruso A, Carlucci T, Constantin G, Rossi B.
    Front Immunol; 2019 Jan 01; 10():2436. PubMed ID: 31681316
    [Abstract] [Full Text] [Related]

  • 39. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.
    Das Sarma J, Ciric B, Marek R, Sadhukhan S, Caruso ML, Shafagh J, Fitzgerald DC, Shindler KS, Rostami A.
    J Neuroinflammation; 2009 Apr 28; 6():14. PubMed ID: 19400960
    [Abstract] [Full Text] [Related]

  • 40. Ruxolitinib attenuates experimental autoimmune encephalomyelitis (EAE) development as animal models of multiple sclerosis (MS).
    Hosseini A, Gharibi T, Mohammadzadeh A, Ebrahimi-Kalan A, Jadidi-Niaragh F, Babaloo Z, Shanehbandi D, Baghbani E, Baradaran B.
    Life Sci; 2021 Jul 01; 276():119395. PubMed ID: 33781828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.